Results 261 to 270 of about 180,156 (374)

Handgrip and coronary flow reserve. [PDF]

Circulation, 1991
openaire   +2 more sources

Sustainable Synthesis, Characterization, Cellular Effects of Gold Nanoparticles and Their Applications as Therapeutics in Cancer Therapy

ChemPlusChem, EarlyView.
Gold nanoparticles (AuNPs) are widely used in biomedicine, electronics, catalysis, and environmental science. Conventional synthesis relies on harsh chemicals, driving interest in eco‐friendly methods using plants, bacteria, fungi, and algae. Biomolecules like polyphenols, proteins, and fatty acids aid nanoparticle synthesis under mild conditions. This
Youfeng Yue, Akihiro Moriyama, Marie Mita, Yue Yu   +3 more
wiley   +1 more source

Inter-Software Reproducibility of Quantitative Values of Myocardial Blood Flow and Coronary Flow Reserve Acquired by [¹³N]NH₃ MPI PET/CT and the Effect of Motion Correction Tools. [PDF]

Diagnostics (Basel)
Mendoza-Ibañez OI, Slart RHJA, Alexanderson-Rosas E, Martinez-Lucio TS, van der Zant FM, Knol RJJ, Lazarenko SV.   +6 more
europepmc   +1 more source

Impaired coronary flow reserve in patients with supra-normal left ventricular ejection fraction at rest. [PDF]

Eur J Nucl Med Mol Imaging, 2022
Wu P, Zhang X, Wu Z, Chen H, Guo X, Jin C, Qin G, Wang R, Wang H, Sun Q, Li L, Yan R, Li X, Hacker M, Li S.   +14 more
europepmc   +1 more source

The absolute and relative coronary flow velocity reserve after lumen enlargement by ultrasound-guided balloon angioplasty and stent implantation

, 1998
Rob A.M van Liebergen, Jan J. Piek, Ron J.G. Peters, K. T. Koch, Robbert J. de Winter, Carl E. Schotborgh   +5 more
openalex   +1 more source

Collateral and collateral-adjacent hyperemic vascular resistance changes and the ipsilateral coronary flow reserve Documentation of a mechanism causing coronary steal in patients with coronary artery disease [PDF]

, 2001
Michael Billinger
openalex   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

Clinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou, Rohit Rao, Monica E. Shapiro, Nessy Tania, Cody Herron, Cynthia J. Musante, Jim H. Hughes   +6 more
wiley   +1 more source

Hidden Coronary Atherosclerosis Assessment but Not Coronary Flow Reserve Helps to Explain the Slow Coronary Flow Phenomenon in Patients with Angiographically Normal Coronary Arteries. [PDF]

Diagnostics (Basel), 2022
Caiati C, Iacovelli F, Mancini G, Lepera ME.   +3 more
europepmc   +1 more source

Acute ischemic dysfunction alters coronary flow reserve in remote nonischemic regions: Potential mechanical etiology identified in an acute canine model

, 2000
Edouard Daher, Donald P. Dione, Eliot N. Heller, John M. Holahan, Paul DeMan, Michael Shen, Jennifer Hu, Albert J. Sinusas   +7 more
openalex   +1 more source

Sustainable Graphite and Jet Fuel from Biorefinery Residue

ChemSusChem, EarlyView.
This study explores the novel conversion of bio‐oil from benzene‐toluene‐xylene (BTX) production into biographite and sustainable aviation fuel (SAF). By replicating synthetic graphite production through coking, calcination, and graphitization, the process yields high‐performance biographite suitable for lithium‐ion batteries.
Lillian Lower, Steven M. Rowland, Michael Regula, Kristiina Iisa, Zachary A. Combs, Sunkyu Park, Tijmen Vries, Ton Vries, Mark R. Nimlos, William Joe Sagues   +9 more
wiley   +1 more source